Login / Signup

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials.

Manu Shankar-HariLise EstcourtHeli HarvalaDavid RobertsDavid K Menonnull null
Published in: Critical care (London, England) (2020)
Keyphrases
  • clinical trial
  • open label
  • double blind
  • phase ii
  • study protocol
  • phase iii
  • randomized controlled trial